INTRODUCTION : The introduction and broad use of new immunosuppressive agents, including biologic agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease [IBD] in recent decades. With such immunosuppression, the potential for opportunistic infection is a key safety con...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!